Half-dose sugammadex with neostigmine versus full-dose sugammadex for reversal of rocuronium in laparoscopic bariatric surgery

Ain-Shams Journal of Anesthesiology

Table 2 Duration of surgery, duration of anesthesia, end tidal isoflurane concentration at the end of the surgery, total rocuronium dose and the interval between the last dose and reverse

Variable	NS group (n = 25)	S group (n = 25)	95% CI of mean difference	P value
Surgery Duration (minutes)	106.6±12.7	113.8±29.4	-20.3,5.8	0.15^a
Anesthesia Duration (minutes)	113.5 ± 12.3	120.8 ± 28.9	-19.9, 5.4	0.14^a
Et- isoflurane Conc. at the end of surgery (%)	1.33 ± 0.31	1.29 ± 0.37	-0.18, 0.22	0.92^a
Total dose of Rocuronium (mg)	88 ± 11.1	90.2 ± 22.3	-12.2, 7.8	0.66^b
D.LRO-Rev. (minutes)	14.1 ± 7.74	15.12 ± 7.67	-5.41, 3.36	0.64^b

Data are expressed as mean and standard deviation. 95% CI: 95% confidence interval. ^aMann Whitney independent samples test, ^bIndependent samples t-test. ^*p is significant when ˂ 0.05. Abbreviations: Et End tidal, Conc. Concentration, D.LRO-Rev. Duration between last dose rocuronium and reverse, group (NS) half dose sugammadex plus neostigmine, group (S) full dose sugammadex group